Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma.
31 auth.
G. Abou-Alfa,
G. Lau,
M. Kudo,
S. Chan,
R. Kelley,
J. Furuse,
W. Sukeepaisarnjaroen,
Yoon-Koo Kang,
T. Van Dao,
E. D. De Toni,
L. Rimassa,
V. Breder,
Alexander Vasilyev,
A. Heurgué,
V. Tam,
...
K. Mody,
S. Thungappa,
Y. Ostapenko,
T. Yau,
S. Azevedo,
M. Varela,
A. Cheng,
S. Qin,
P. Galle,
Sajid Ali,
M. Marcovitz,
M. Makowsky,
P. He,
J. Kurland,
A. Negro,
B. Sangro
|
9 |
2022 |
9
2022
|
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer.
29 auth.
D. Oh,
A. Ruth He,
S. Qin,
Li‐Tzong Chen,
T. Okusaka,
A. Vogel,
J. W. Kim,
T. Suksombooncharoen,
Myung Ah Lee,
Masayuki Kitano,
H. Burris,
M. Bouattour,
S. Tanasanvimon,
M. McNamara,
R. Zaucha,
...
A. Avallone,
Benjamin Tan,
J. Cundom,
Choong-kun Lee,
Hidenori Takahashi,
M. Ikeda,
Jen‐Shi Chen,
Julie Wang,
M. Makowsky,
N. Rokutanda,
P. He,
J. Kurland,
G. Cohen,
J. Valle
|
8 |
2022 |
8
2022
|
Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate Cancer.
25 auth.
N. Clarke,
A. Armstrong,
A. Thiery-Vuillemin,
M. Oya,
N. Shore,
E. Loredo,
G. Procopio,
J. de Menezes,
G. Girotto,
Ç. Arslan,
N. Mehra,
F. Parnis,
E. Brown,
F. Schlürmann,
J. Joung,
...
M. Sugimoto,
J. Virizuela,
U. Emmenegger,
J. Navrátil,
G. Buchschacher,
C. Poehlein,
E. Harrington,
C. Desai,
Jinyu Kang,
F. Saad
|
7 |
2022 |
7
2022
|
Prediction of risk for myeloid malignancy in clonal hematopoiesis.
19 auth.
L. Weeks,
A. Niroula,
D. Neuberg,
W. Wong,
R. C. Lindsley,
M. Luskin,
N. Berliner,
R. Stone,
D. DeAngelo,
R. Soiffer,
...
M. Uddin,
G. Griffin,
C. Vlasschaert,
C. Gibson,
S. Jaiswal,
A. Bick,
L. Malcovati,
P. Natarajan,
B. Ebert
|
7 |
2022 |
7
2022
|
Low-Voltage Myocardium-Guided Ablation Trial of Persistent Atrial Fibrillation.
17 auth.
Y. Huo,
T. Gaspar,
R. Schönbauer,
M. Wójcik,
L. Fiedler,
F. Roithinger,
M. Martinek,
H. Pürerfellner,
B. Kirstein,
U. Richter,
...
S. Ulbrich,
J. Mayer,
O. Krahnefeld,
Tolga Agdirlioglu,
A. Zedda,
J. Piorkowski,
C. Piorkowski
|
6 |
2022 |
6
2022
|
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.
64 auth.
E. Bernard,
H. Tuechler,
P. Greenberg,
R. Hasserjian,
J. A. Arango Ossa,
Y. Nannya,
Sean M Devlin,
M. Creignou,
Philippe Pinel,
Lily Monnier,
G. Gundem,
J. Medina-Martinez,
D. Domenico,
M. Jädersten,
U. Germing,
...
Guillermo Sanz,
A. A. van de Loosdrecht,
O. Kosmider,
M. Follo,
F. Thol,
L. Zamora,
R. F. Pinheiro,
A. Pellagatti,
H. K. Elias,
D. Haase,
C. Ganster,
L. Adès,
M. Tobiasson,
L. Palomo,
M. D. Della Porta,
A. Takaori-Kondo,
Takayuki Ishikawa,
Shigeru Chiba,
S. Kasahara,
Yasushi Miyazaki,
A. Viale,
K. Huberman,
P. Fenaux,
M. Belickova,
M. Savona,
V. Klimek,
Fabio P S Santos,
J. Boultwood,
Ioannis Kotsianidis,
V. Santini,
Francesc Solé,
U. Platzbecker,
M. Heuser,
P. Valent,
Kazuma Ohyashiki,
C. Finelli,
M. Voso,
L. Shih,
M. Fontenay,
J. Jansen,
José Cervera,
N. Gattermann,
Benjamin L Ebert,
R. Bejar,
L. Malcovati,
Mario Cazzola,
S. Ogawa,
E. Hellström-Lindberg,
E. Papaemmanuil
|
6 |
2022 |
6
2022
|
Fixed-Duration Ibrutinib-Venetoclax in Patients with Chronic Lymphocytic Leukemia and Comorbidities.
21 auth.
A. Kater,
C. Owen,
C. Moreno,
G. Follows,
T. Munir,
M. Levin,
O. Benjamini,
A. Janssens,
A. Osterborg,
T. Robak,
...
M. Šimkovič,
D. Stevens,
S. Voloshin,
V. Vorobyev,
L. Ysebaert,
R. Qin,
A. Steele,
N. Schuier,
K. Baeten,
D. B. Caces,
C. Niemann
|
6 |
2022 |
6
2022
|
Efficacy of single-dose HPV vaccination among young African women
25 auth.
Ruanne V. Barnabas,
E. Brown,
M. Onono,
E. Bukusi,
B. Njoroge,
R. Winer,
D. Galloway,
L. Pinder,
D. Donnell,
Imeldah Wakhungu,
Ouma Congo,
Charlene Biwott,
Syovata Kimanthi,
L. Oluoch,
Kate B. Heller,
...
Hannah Leingang,
Susan Morrison,
E. Rechkina,
S. Cherne,
T. Schaafsma,
R. Mcclelland,
C. Celum,
J. Baeten,
N. Mugo,
for the Hivaids Prevention Research Synthesis Team
|
6 |
2021 |
6
2021
|
Five-Year Analysis of Adjuvant Pembrolizumab or Placebo in Stage III Melanoma.
30 auth.
A. Eggermont,
M. Kicinski,
C. Blank,
M. Mandalà,
G. Long,
V. Atkinson,
S. Dalle,
A. Haydon,
A. Meshcheryakov,
A. Khattak,
M. Carlino,
S. Sandhu,
J. Larkin,
S. Puig,
P. Ascierto,
...
P. Rutkowski,
D. Schadendorf,
M. Boers-Sonderen,
A. D. di Giacomo,
A. van den Eertwegh,
J. Grob,
R. Gutzmer,
R. Jamal,
A. V. van Akkooi,
P. Lorigan,
Dmitri O. Grebennik,
C. Krepler,
S. Marréaud,
S. Suciu,
C. Robert
|
6 |
2022 |
6
2022
|
Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19.
20 auth.
J. Arribas,
S. Bhagani,
S. Lobo,
I. Khaertynova,
L. Mateu,
R. Fishchuk,
W. Y. Park,
K. Hussein,
S. Kim,
J. Ghosn,
...
M. Brown,
Ying Zhang,
Wei Gao,
C. Assaid,
J. Grobler,
J. Strizki,
Mary Vesnesky,
Amanda Paschke,
J. Butterton,
Carisa De Anda
|
6 |
2021 |
6
2021
|
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure.
21 auth.
Stefan James,
D. Erlinge,
Robert F Storey,
Darren K. McGuire,
M. de Belder,
N. Eriksson,
Kasper Andersen,
D. Austin,
G. Arefalk,
D. Carrick,
...
R. Hofmann,
S. Hoole,
Daniel A. Jones,
Kelvin Lee,
Hans Tygesen,
P. A. Johansson,
A. Langkilde,
W. Ridderstråle,
E. Parvaresh Rizi,
J. Deanfield,
Jonas Oldgren
|
6 |
2024 |
6
2024
|
Phentermine/Topiramate for the Treatment of Adolescent Obesity.
7 auth.
A. Kelly,
Megan O. Bensignor,
D. Hsia,
Ashley H. Shoemaker,
W. Shih,
C. Peterson,
...
S. Varghese
|
6 |
2022 |
6
2022
|